Sanjaya Kumar

Managing Director, Synepta Group, Inc.

📍 Pleasanton, California, United States🔄 Updated September 2026💼 7 investments📅 15 years investing🗓 Last invested Jan 2019
Operator-angel🌍 United States
7
Total investments
3
Early stage
2
Mid stage
0
Late stage
15y
Years active

Portfolio

5 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
BoD Member & Investor
Jan 2019
Seqnc Inc. provides a cloud-based SaaS application for financial planning and analysis. Our innovative solution empowers businesses to develop financial plans, budgets, estimate capital requirements, track performance, and forecast metrics. Our product is designed especially for recurring and hybrid business models due to their unique financial modeling and specialized metrics such as MRR, LTV, churn, TCV, backlog, and deferred revenues. The company, based in the SF Bay Area is led by an enthusiastic team with broad finance and technology expertise.
Medical Informatics Advisory Board Member & Investor
Mar 2018
Hemex Health focuses on commercializing proven research into cost-effective, intuitive devices optimized to make diagnostics more accessible at the front lines of healthcare. Our products are designed to be easy to use and provide benefit quickly and effectively for the healthcare worker and patient on the ground, at the point-of-need. The company’s leaders, with backgrounds in international business and biomedical engineering, have decades of success in developing and delivering more than 60 products that have made a difference in people’s lives. We leverage our experience in building successful medical products to solve major needs in global health. Our low-cost technologies are targeted for the developing world and can impact millions by identifying diseases which can be affordably treated. Hemex is developing a diagnostic platform (utilizing technology which received a 2016 Patents for Humanity Award) that can quickly and easily diagnose hemoglobin disorders, such as sickle cell disease and beta thalassemia, from a drop of blood. The solution provides point-of-care access to diagnostic information faster, more cost-effectively, and more accurately than any solution on the market today. Hemex is an equal opportunity employer. All employment-related decisions are based solely upon one’s individual merit and qualifications directly related to professional competence, and without regard to race, color, religion, national origin, pregnancy status, sex (gender}, age, marital status, mental or physical disability, sexual orientation, gender identity, military or veteran status, genetic history, or any other characteristic or classification protected by applicable law. We will also attempt to reasonably accommodate an individual based on his/her physical or mental limitation or because of the individual’s sincerely held religious beliefs.
Investor (Through TiE Angels) & Advisor
2014
Oration focuses on enabling large self Insured employers and state payers such as Medicaid to manage their healthcare spend which is the only tractable way to influence and pressure the healthcare industry to optimize the delivery system. Asking a sub $3T industry to heal itself isn't a strategy that will yield outcomes other than consistently rising prices. We help employers and employees to stop buying the proverbial $200 hammers in healthcare. Ultimately we help employers and employees share in the savings that would have been lost to the healthcare system.
Investor & Advisor
2012
Viewics (Acquired by Roche) provides unprecedented access to disparate healthcare data to surface actionable intelligence and empower data-driven decision-making. Through expertise and focus on healthcare analytics, Viewics delivers proprietary, best-in-class technology for data extraction, cleansing, and transformation to quickly unlock insights that deliver invaluable operational and financial impact, while reducing burden on IT. The HIPAA-compliant solution puts the transformational power of analytics into the hands of healthcare professionals in financial, operational, and IT roles. The solution is customized and supported to enable organizations to move with agility, make decisions based on accurate data, see insights at-a-glance, and deliver great impact.
Investor (Through TiE Angels)
2011
PubNub, the worlds biggest pub/sub network, is now a complete platform for building, managing, and monetizing real-time interactive experiences in any app, regardless of purpose, scale, or complexity. Whether you’re in the early development phase and want to get to market faster, or you are looking to increase engagement and accelerate monetization in your existing app, PubNub provides the economies of scale and expertise necessary to grow your business at any speed while freeing your developers to focus on core initiatives. Over 2000 companies worldwide, including Amazon, RingCentral, Gameloft, and DAZN, choose PubNub to scale faster, reduce risk, and accelerate growth.
Experience · 10 entries
All (10)
Investments (7)
Founder (2)
2019
BoD Member & Investor
Jan 2019
Seqnc Inc. provides a cloud-based SaaS application for financial planning and analysis. Our innovative solution empowers businesses to develop financial plans, budgets, estimate capital requirements, track performance, and forecast metrics. Our product is designed especially for recurring and hybrid business models due to their unique financial modeling and specialized metrics such as MRR, LTV, churn, TCV, backlog, and deferred revenues. The company, based in the SF Bay Area is led by an enthusiastic team with broad finance and technology expertise.
2018
Medical Informatics Advisory Board Member & Investor
Mar 2018
Hemex Health focuses on commercializing proven research into cost-effective, intuitive devices optimized to make diagnostics more accessible at the front lines of healthcare. Our products are designed to be easy to use and provide benefit quickly and effectively for the healthcare worker and patient on the ground, at the point-of-need. The company’s leaders, with backgrounds in international business and biomedical engineering, have decades of success in developing and delivering more than 60 products that have made a difference in people’s lives. We leverage our experience in building successful medical products to solve major needs in global health. Our low-cost technologies are targeted for the developing world and can impact millions by identifying diseases which can be affordably treated. Hemex is developing a diagnostic platform (utilizing technology which received a 2016 Patents for Humanity Award) that can quickly and easily diagnose hemoglobin disorders, such as sickle cell disease and beta thalassemia, from a drop of blood. The solution provides point-of-care access to diagnostic information faster, more cost-effectively, and more accurately than any solution on the market today. Hemex is an equal opportunity employer. All employment-related decisions are based solely upon one’s individual merit and qualifications directly related to professional competence, and without regard to race, color, religion, national origin, pregnancy status, sex (gender}, age, marital status, mental or physical disability, sexual orientation, gender identity, military or veteran status, genetic history, or any other characteristic or classification protected by applicable law. We will also attempt to reasonably accommodate an individual based on his/her physical or mental limitation or because of the individual’s sincerely held religious beliefs.
2015
Velocitos Inc.
Chief Medical Informatics Officer, Cofounder, BoD
Mar 2015
2014
Investor (Through TiE Angels) & Advisor
2014
Oration focuses on enabling large self Insured employers and state payers such as Medicaid to manage their healthcare spend which is the only tractable way to influence and pressure the healthcare industry to optimize the delivery system. Asking a sub $3T industry to heal itself isn't a strategy that will yield outcomes other than consistently rising prices. We help employers and employees to stop buying the proverbial $200 hammers in healthcare. Ultimately we help employers and employees share in the savings that would have been lost to the healthcare system.
2012
Synepta Group, Inc.
Managing Director
Jan 2012
Show all 10 entries ↓
Investment activity
2011–2019 · 7 investments
2011220122201412018120191
Recent (last 2 years)Earlier